CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study (vol 13, 44, 2023)

被引：0
|
作者：
Niu, Jiahua [1 ,2 ]
Qiu, Huiying [1 ,2 ]
Xiang, Fang [3 ]
Zhu, Lin [3 ]
Yang, Jun [1 ,2 ]
Huang, Chongmei [1 ,2 ]
Zhou, Kun [1 ,2 ]
Tong, Yin [1 ,2 ]
Cai, Yu [1 ,2 ]
Dong, Baoxia [1 ,2 ]
Lu, Yuan [3 ]
Sun, Xuedong [3 ]
Wan, Liping [1 ,2 ]
Ding, Xueying [2 ]
Wang, Haopeng [4 ]
Song, Xianmin [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Hematol, Shanghai, Peoples R China
[2] Shanghai Sci & Technol Comm STCSM, Engn Technol Res Ctr Cell Therapy & Clin Translat, Shanghai, Peoples R China
[3] Hrain Biotechnol, Shanghai, Peoples R China
[4] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
来源：
BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期
基金：
国家重点研发计划;
关键词：
D O I：
10.1038/s41408-023-00825-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia
    Gardner, Rebecca
    Annesley, Colleen
    Finney, Olivia
    Summers, Corinne
    Lamble, Adam J.
    Rivers, Julie
    Crews, Kaelin
    Huang, Lauren
    Brown, Christopher
    Mgebroff, Stephanie
    Lindgren, Catherine
    Spratt, Karen
    Gustafson, Josh
    Johnson, Adam
    Park, Julie R.
    Jensen, Michael C.
    BLOOD, 2018, 132
  • [32] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Jing Pan
    Qing Niu
    Biping Deng
    Shuangyou Liu
    Tong Wu
    Zhiyong Gao
    Zhaoli Liu
    Yue Zhang
    Xiaomin Qu
    Yanlei Zhang
    Shaohui Liu
    Zhuojun Ling
    Yuehui Lin
    Yongqiang Zhao
    Yanzhi Song
    Xiyou Tan
    Yan Zhang
    Zhihui Li
    Zhichao Yin
    Bingzhen Chen
    Xinjian Yu
    Ju Yan
    Qinlong Zheng
    Xuan Zhou
    Jin Gao
    Alex H. Chang
    Xiaoming Feng
    Chunrong Tong
    Leukemia, 2019, 33 : 2854 - 2866
  • [33] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Jing, P.
    Niu, Q.
    Deng, B.
    Liu, S.
    Wu, T.
    Gao, Z.
    Chang, A. H.
    Feng, X.
    Tong, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1723 - 1723
  • [34] CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia
    Pan, Jing
    Niu, Qing
    Deng, Biping
    Liu, Shuangyou
    Wu, Tong
    Gao, Zhiyong
    Liu, Zhaoli
    Zhang, Yue
    Qu, Xiaomin
    Zhang, Yanlei
    Liu, Shaohui
    Ling, Zhuojun
    Lin, Yuehui
    Zhao, Yongqiang
    Song, Yanzhi
    Tan, Xiyou
    Zhang, Yan
    Li, Zhihui
    Yin, Zhichao
    Chen, Bingzhen
    Yu, Xinjian
    Yan, Ju
    Zheng, Qinlong
    Zhou, Xuan
    Gao, Jin
    Chang, Alex H.
    Feng, Xiaoming
    Tong, Chunrong
    LEUKEMIA, 2019, 33 (12) : 2854 - 2866
  • [35] Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma
    Roddie, Claire
    Lekakis, Lazaros J.
    Marzolini, Maria A. V.
    Ramakrishnan, Aravind
    Zhang, Yiyun
    Hu, Yanqing
    Peddareddigari, Vijay G. R.
    Khokhar, Nushmia
    Chen, Robert
    Basilico, Silvia
    Raymond, Meera
    Vargas, Frederick Arce
    Duffy, Kevin
    Brugger, Wolfram
    O'Reilly, Maeve A.
    Wood, Leigh
    Linch, David C.
    Peggs, Karl S.
    Bachier, Carlos
    Budde, Elizabeth Lihua
    Batlevi, Connie Lee
    Bartlett, Nancy
    Irvine, David
    Tholouli, Eleni
    Osborne, Wendy
    Ardeshna, Kirit M.
    Pule, Martin A.
    BLOOD, 2023, 141 (20) : 2470 - 2482
  • [36] Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro
    L Herrera
    RA Farah
    VA Pellegrini
    DB Aquino
    ES Sandler
    GR Buchanan
    ES Vitetta
    Leukemia, 2000, 14 : 853 - 858
  • [37] Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro
    Herrera, L
    Farah, RA
    Pellegrini, VA
    Aquino, DB
    Sandler, ES
    Buchanan, GR
    Vitetta, ES
    LEUKEMIA, 2000, 14 (05) : 853 - 858
  • [38] CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia
    Pacenta, Holly L.
    Laetsch, Theodore W.
    John, Samuel
    PEDIATRIC DRUGS, 2020, 22 (01) : 1 - 11
  • [39] CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia
    Holly L. Pacenta
    Theodore W. Laetsch
    Samuel John
    Pediatric Drugs, 2020, 22 : 1 - 11
  • [40] DUAL CD19/CD22 CAR T CELLS SHOW FEASIBILITY IN PEDIATRIC/YOUNG ADULT B-ALL
    不详
    CANCER DISCOVERY, 2021, 11 (12) : 2958 - 2958
12345